Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Daan Touw"'
Autor:
Leandro F. Pippa, Valvanera Vozmediano, Lieke Mitrov‐Winkelmolen, Daan Touw, Amira Soliman, Rodrigo Cristofoletti, Wilson Salgado Junior, Natalia Valadares de Moraes
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 9, Pp 1528-1541 (2024)
Abstract This study employed physiologically‐based pharmacokinetic–pharmacodynamics (PBPK/PD) modeling to predict the effect of obesity and gastric bypass surgery on the pharmacokinetics and intragastric pH following omeprazole treatment. The sim
Externí odkaz:
https://doaj.org/article/5a65cde4a533494db54a046517658249
Publikováno v:
Journal of Diabetes Research, Vol 2024 (2024)
Aims. To investigate the effect of serotonin transporter (5-HTT) polymorphisms on change in HbA1c levels six months after metformin initiation in type 2 diabetes patients. Materials and Methods. Participants of PROVALID (PROspective cohort study in p
Externí odkaz:
https://doaj.org/article/d9b8afe506f24094b9bfb4bae02b6973
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1149 (2023)
(1) Introduction: Pharmacokinetic boosting of kinase inhibitors can be a strategy to enhance drug exposure and to reduce dose and associated treatment costs. Most kinase inhibitors are predominantly metabolized by CYP3A4, enabling boosting using CYP3
Externí odkaz:
https://doaj.org/article/dfa3f1ad0cad4ef992c575258711783a
Autor:
Lianne Beunk, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne-Marie Buunk, Henk Jan Guchelaar, Elisa J. F. Houwink, Arne Risselada, Gerard A. P. J. M. Rongen, Ron H. N. van Schaik, Jesse J. Swen, Daan Touw, Roos van Westrhenen, Vera H. M. Deneer, Jan van der Weide
Publikováno v:
European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate pharmacogenetics implementation in clinical practice by developing evidence-based guidelines to optimize pharmacotherapy. A guideline describing the gene-drug interaction between the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d87804d4af6dcbaf1b5d9f3f194979
https://cris.maastrichtuniversity.nl/en/publications/8434c9e0-c985-4bc8-a492-71fb47e9fdc5
https://cris.maastrichtuniversity.nl/en/publications/8434c9e0-c985-4bc8-a492-71fb47e9fdc5
Autor:
Marga Nijenhuis, Bianca Soree, Wafa O. M. Jama, Nienke J. de Boer-Veger, Anne Marie Buunk, Henk-Jan Guchelaar, Elisa J. F. Houwink, Gerard A. Rongen, Ron H. N. van Schaik, Jesse J. Swen, Daan Touw, Jan van der Weide, Roos van Westrhenen, Vera H. M. Deneer, Arne Risselada
Publikováno v:
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics
European Journal of Human Genetics. Nature Publishing Group
Pharmacogenetics (PGx) studies the effect of heritable genetic variation on drug response. Clinical adoption of PGx has remained limited, despite progress in the field. To promote implementation, the Dutch Pharmacogenetics Working Group (DPWG) develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f755520f566484b90f85d4cb382e207
http://hdl.handle.net/1887/3515272
http://hdl.handle.net/1887/3515272
Autor:
Marga Nijenhuis, Bianca Soree, Wafa Jama, Nienke de Boer-Veger, Anne Marie Buunk, Henk-Jan Guchelaar, Isa Houwink, Gerard Rongen, Ron van Schaik, Jesse Swen, Daan Touw, Jan van der Weide, Roos van Westrhenen, Vera Deneer, Arne Risselada
Pharmacogenetics (PGx) studies the effect of heritable genetic variation on drug response. Clinical adoption of PGx has remained limited, despite progress in the field. To promote implementation, the Dutch Pharmacogenetics Working Group (DPWG) develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1902f125d5f9410237e970166bec6b33
https://doi.org/10.21203/rs.3.rs-2134851/v1
https://doi.org/10.21203/rs.3.rs-2134851/v1
Autor:
Marga, Nijenhuis, Bianca, Soree, Wafa O M, Jama, Nienke J, de Boer-Veger, Anne Marie, Buunk, Henk-Jan, Guchelaar, Elisa J F, Houwink, Gerard A, Rongen, Ron H N, van Schaik, Jesse J, Swen, Daan, Touw, Jan, van der Weide, Roos, van Westrhenen, Vera H M, Deneer, Arne, Risselada
Publikováno v:
European journal of human genetics : EJHG.
Pharmacogenetics (PGx) studies the effect of heritable genetic variation on drug response. Clinical adoption of PGx has remained limited, despite progress in the field. To promote implementation, the Dutch Pharmacogenetics Working Group (DPWG) develo
Autor:
Karel H. van der Pol, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer-Veger, Anne Marie Buunk, Henk-Jan Guchelaar, Arne Risselada, Ron H. N. van Schaik, Jesse J. Swen, Daan Touw, Jan van der Weide, Roos van Westrhenen, Vera H. M. Deneer, Elisa J. F. Houwink, Gerard A. Rongen
Publikováno v:
European Journal of Human Genetics. Nature Publishing Group
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
European Journal of Human Genetics. SPRINGERNATURE
European Journal of Human Genetics
The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate PGx implementation by developing evidence-based pharmacogenetics guidelines to optimize pharmacotherapy. This guideline describes the gene-drug interaction of ABCG2 with allopurinol,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6cec37152e6fc9e7daaa1ea1275fd4f
https://hdl.handle.net/1887/3458834
https://hdl.handle.net/1887/3458834
SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function
Autor:
Danii L.S. Suijk, Michaël J.B. van Baar, Erik J.M. van Bommel, Zainab Iqbal, Merle M. Krebber, Volker Vallon, Daan Touw, Ewout J. Hoorn, Max Nieuwdorp, Mark M.H. Kramer, Jaap A. Joles, Petter Bjornstad, Daniël H. van Raalte
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN, 17(5), 663-671. AMER SOC NEPHROLOGY
Clinical Journal of the American Society of Nephrology, 17(5), 663-671. American Society of Nephrology
Clin J Am Soc Nephrol
Clinical journal of the American Society of Nephrology, 17(5), 663-671. American Society of Nephrology
Clinical Journal of the American Society of Nephrology, 17(5), 663-671. American Society of Nephrology
Clin J Am Soc Nephrol
Clinical journal of the American Society of Nephrology, 17(5), 663-671. American Society of Nephrology
Background and objectives Sodium-glucose transporter 2 (SGLT2) inhibitor–induced uric acid lowering may contribute to kidney-protective effects of the drug class in people with type 2 diabetes. This study investigates mechanisms of plasma uric acid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3f093cfe410e80a96d74efcfec213ab
https://research.rug.nl/en/publications/027ee923-755b-4586-b6ed-604fedf8fee8
https://research.rug.nl/en/publications/027ee923-755b-4586-b6ed-604fedf8fee8
Publikováno v:
Acta Oto-Laryngologica. :1-6